Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVB
#3994
Nuvation Bio Inc.
5.9
2
+5.71%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+5.71%
Monthly Change
+5.53%
6 month change
+98.66%
Cambio anual
+203.59%
Cierres anteriores
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
Volumen
1 640
Markets
Acciones
Atención Sanitaria
NUVB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
216.65 M
218.06 M
217.8 M
218.05 M
337.68 M
—
Valuation ratios
Enterprise value
—
18.62 T
4.44 T
645.16 M
1.77 B
4.12 B
Price to earnings ratio
—
—
-4.21
-4.49
-1.26
-13.64
Price to sales ratio
—
—
-0.37
-2.66
0.09
0.22
Price to cash flow ratio
—
—
0
0.01
0.01
0.02
Price to book ratio
—
—
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.11
-0.16
-0.12
-1.05
-0.38
Return on equity %
—
-0.12
-0.16
-0.13
-1.22
-0.56
Return on invested capital %
—
-502.05
-8 731.74
-6 118.89
-11.72 K
-2 524.3
Gross margin %
—
100
100
100
10.1
179.45
Operating margin %
—
-54.25 K
10.16 K
77.38 K
-7 527.33
-4 603.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-50.49 K
8 845.42
58.76 K
-7 213.76
-4 238.15
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.46
45.62
50.7
44.11
9.04
35.92
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
-0
-0
0.01
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-443.46
-310.67
-485.22
-595.27
EBIT per share
—
—
—
—
-2 204.94
-727.84
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3 050.07
2 792.46
1 870.33
6 634.85
Net current asset value per share
—
—
3 079.16
2 816.31
1 958
6 892.76
Tangible book value per share
—
—
3 022.67
2 764.63
1 708.38
4 918.68
Working capital per share
—
—
3 018.43
2 752.47
1 741.29
6 124.83
Book value per share
—
—
3 022.67
2 764.63
1 725.58
5 018.94
Noticias
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio amplía ensayo SIGMA a fase 3 para glioma con mutación IDH1
Nuvation Bio amplía el ensayo SIGMA a fase 3 para glioma con mutación IDH1
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Nuvation Bio mantiene calificación de Compra en B.Riley por impulso de ventas de Ibtrozi
Acción de Nuvation Bio mantiene calificación de Compra por impulso en ventas de Ibtrozi
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Truist Securities eleva el precio objetivo de Nuvation Bio a 13 dólares por la adopción de Ibtrozi
Truist Securities eleva precio objetivo de Nuvation Bio a $13 por adopción de Ibtrozi
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake